Document is current
Any future updates will be listed below
-
Authors
Mühlenbruch, Lena
Abou-Kors, Tsima
Dubbelaar, Marissa L.
Bichmann, Leon
Kohlbacher, Oliver https://orcid.org/0000-0003-1739-4598
Bens, Martin
Thomas, Jaya
Ezić, Jasmin
Kraus, Johann M.
Kestler, Hans A.
von Witzleben, Adrian
Mytilineos, Joannis
Fürst, Daniel
Engelhardt, Daphne
Doescher, Johannes
Greve, Jens
Schuler, Patrick J.
Theodoraki, Marie-Nicole https://orcid.org/0000-0002-5491-1593
Brunner, Cornelia
Hoffmann, Thomas K.
Rammensee, Hans-Georg
Walz, Juliane S.
Laban, Simon https://orcid.org/0000-0001-6732-7137
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (288342734, 288342734, 416718265, 288342734, 288342734)
1. Ernst Jung-Preis für Medizin 2. Landesforschungspreis Baden-Württemberg
Universität Ulm - Clinician Scientist Programme
- License Information
-
More Information
Article History
Received: 13 September 2022
Revised: 24 January 2023
Accepted: 1 February 2023
First Online: 23 February 2023
Competing interests
: LM, TKH, JSW, HGR and SL have filed a patent for the peptide warehouse described in this manuscript (patent pending). SL: Advisory Boards: Merck Sharp & Dohme (MSD), Bristol Myers Squibb (BMS), Sanofi Genzyme, Astra Zeneca (AZ). Honoraria: MSD, BMS. Travel reimbursement: Merck Serono, Astra Zeneca.
: Informed written consent was obtained in accordance with the Declaration of Helsinki protocol. The study was performed according to the guidelines of the local ethics committee (222/13, 90/15).
: Informed written consent was obtained in accordance with the Declaration of Helsinki protocol.
